Ingevity Corporation NGVT
61.96 USD -1.28 (-2.02%)
At closeNov 12, 2026, 4:00 PM EST
61.97 +0.01 +0.01%
After hours · Nov 12, 4:00 PM ET
61.92 Day range 63.44
46.38 52-week range 79.29
- YTD
- +4.70%
- 1 year
- +26.07%
News
marketbeat.com Ingevity Q3 Earnings Call Highlights Ingevity NYSE: NGVT reported lower third-quarter sales following a divestiture but expanded its adjusted profit margin, as executives pointed to growth in filtration and continued demand from North…
seekingalpha.com Ingevity Corporation (NGVT) Q3 2026 Earnings Call Transcript Ingevity Corporation ( NGVT ) Q3 2026 Earnings Call November 5, 2026 10:00 AM EST Company Participants Michael Walsh - Vice President of Investor Relations David Li - President, CEO & Director…
benzinga.com Ingevity Q3 2026 Earnings Call Transcript Ingevity (NYSE:NGVT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Ingevity Raises FY2026 Adj EPS Guidance from $5.00-$5.45 to $5.25-$5.45 vs $5.36 Est; Narrows FY2026 Sales Guidance from $1.050B-$1.150B to $1.100B vs $1.114B Est Ingevity (NYSE:NGVT) raises FY2026 Adj EPS guidance from $5.00-$5.45 to $5.25-$5.45 vs $5.36 analyst estimate. Narrows FY2026 sales outlook from $1.050 billion-$1.150 billion to $1.100 billion vs…- benzinga.com Ingevity Q3 Adj. EPS $1.63 Beats $1.57 Estimate, Sales $305.100M Beat $304.600M Estimate Ingevity (NYSE:NGVT) reported quarterly earnings of $1.63 per share which beat the analyst consensus estimate of $1.57 by 3.82 percent. This is a 24.43 percent increase over earnings of $1.31 per…
benzinga.com Ingevity Raises FY2026 Adj EPS Guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 Est; Affirms FY2026 Sales Guidance of $1.050B-$1.150B vs $1.109B Est Ingevity (NYSE:NGVT) raises FY2026 Adj EPS guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 analyst estimate. Affirms FY2026 sales outlook from $1.050 billion-$1.150 billion to $1.050 billion-$1.150…- benzinga.com Ingevity Q2 Adj. EPS $1.74 Beats $1.33 Estimate, Sales $314.100M Beat $312.200M Estimate Ingevity (NYSE:NGVT) reported quarterly earnings of $1.74 per share which beat the analyst consensus estimate of $1.33 by 30.83 percent. This is a 42.62 percent increase over earnings of $1.22 per…
benzinga.com Ingevity’s Evotherm P35 Secures BASt Approval For Warm‑Mix Asphalt In Germany Approval reflects alignment with evolving regulatory and performance standard for German market requirementsIngevity Corporation (NYSE:NGVT) today announced Evotherm® P35 warm-mix additive has…
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com Ingevity Widens FY2026 Adj EPS Guidance from $4.80-$5.20 to $4.70-$5.20 vs $4.80 Est; Lowers FY2026 Sales Guidance from $1.100B-$1.200B to $1.050B-$1.150B vs $1.187B Est Ingevity (NYSE:NGVT) widens FY2026 Adj EPS guidance from $4.80-$5.20 to $4.70-$5.20 vs $4.80 analyst estimate. Lowers FY2026 sales outlook from $1.100 billion-$1.200 billion to $1.050 billion-$1.150…
benzinga.com Ingevity Q1 Adj. EPS $1.15 Beats $0.78 Estimate, Sales $258.000M Beat $254.733M Estimate Ingevity (NYSE:NGVT) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $0.78 by 47.44 percent. This is a 16.16 percent increase over earnings of $0.99 per…
benzinga.com PPG Acquires Ozark Materials From Ingevity; All-Cash Transaction Includes Purchase Price Of $65M PPG (NYSE:PPG) today announced that it has completed the acquisition of Ozark Materials, LLC, a U.S.-based provider of pavement marking solutions, from Ingevity Corporation (NYSE:NGVT). The all-cash…
benzinga.com Ingevity Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - benzinga.com Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $75 Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $65 to $75.
- benzinga.com Ingevity Sees FY2026 Adj EPS $4.80-$5.20 vs $4.71 Est; Sees Sales $1.100B-$1.200B vs $1.224B Est Ingevity (NYSE:NGVT) is looking for FY2026 Adj EPS of $4.80-$5.20 vs $4.71 analyst estimate. sees sales of $1.100 billion-$1.200 billion vs $1.224 billion analyst estimate.
- benzinga.com Ingevity: Q4 Earnings Insights
benzinga.com Ingevity Q4 Adj. EPS $0.64 Misses $0.69 Estimate, Sales $255.100M Miss $257.267M Estimate Ingevity (NYSE:NGVT) reported quarterly earnings of $0.64 per share which missed the analyst consensus estimate of $0.69 by 6.98 percent. This is a 32.63 percent decrease over earnings of $0.95 per…- benzinga.com Earnings Scheduled For February 25, 2026
benzinga.com Ingevity Earnings Preview 
benzinga.com 4 Analysts Assess Ingevity: What You Need To Know - benzinga.com Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $65 Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $60 to $65.
benzinga.com Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $60 Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $55 to $60.- benzinga.com BMO Capital Maintains Outperform on Ingevity, Raises Price Target to $70 BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $64 to $70.
benzinga.com Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $55 Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $52 to $55.- benzinga.com Ingevity Narrows FY2025 Sales Guidance from $1.250B-$1.400B to $1.250B-$1.350B vs $1.276B Est Ingevity (NYSE:NGVT) narrows FY2025 sales outlook from $1.250 billion-$1.400 billion to $1.250 billion-$1.350 billion vs $1.276 billion estimate.
- benzinga.com Ingevity Q3 Adj. EPS $1.31 Misses $1.39 Estimate, Sales $362.100M Beat $360.433M Estimate Ingevity (NYSE:NGVT) reported quarterly earnings of $1.31 per share which missed the analyst consensus estimate of $1.39 by 5.76 percent. This is a 1.5 percent decrease over earnings of $1.33 per…
benzinga.com Earnings Scheduled For November 5, 2025 - benzinga.com BMO Capital Maintains Outperform on Ingevity, Raises Price Target to $68 BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $62 to $68.
benzinga.com Ingevity To Sell North Charleston CTO Refinery And Performance Chemicals Industrial Specialties Product Line To Mainstream For $110M Plus Up To $19M Contingent Payout Divestiture reduces portfolio volatility, strengthens Ingevity's margin and cash flow profile and enhances future strategic optionalityThe all-cash transaction includes $110 million at closing plus…- benzinga.com BMO Capital Maintains Outperform on Ingevity, Raises Price Target to $62 BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $56 to $62.
- benzinga.com Ingevity Affirms FY2025 Sales Guidance of $1.250B-$1.400B vs $1.330B Est Ingevity (NYSE:NGVT) affirms FY2025 sales outlook from $1.250 billion-$1.400 billion to $1.250 billion-$1.400 billion vs $1.330 billion estimate.
- benzinga.com Ingevity Q2 Adj. EPS $1.39 Beats $1.16 Estimate, Sales $365.100M Miss $378.700M Estimate Ingevity (NYSE:NGVT) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.16 by 19.52 percent. This is a 37.62 percent increase over earnings of $1.01 per…
- benzinga.com Earnings Scheduled For August 4, 2025
- benzinga.com Wells Fargo Maintains Equal-Weight on Ingevity, Raises Price Target to $48 Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises the price target from $38 to $48.
- benzinga.com Ingevity Expands Capa Caprolactone Distribution Network By Establishing Jamplast As Exclusive Distributor For Capa TP For Bioplastics In US And Canada Ingevity Corporation (NYSE:NGVT) today announced the expansion of its Capa® caprolactone distribution network by establishing Jamplast as its exclusive distributor for Capa TP for bioplastics in the…
- benzinga.com Earnings Scheduled For May 5, 2025
- benzinga.com Earnings Scheduled For February 18, 2025
- benzinga.com AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
- benzinga.com Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
- benzinga.com Earnings Scheduled For February 21, 2024 Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
benzinga.com Earnings Scheduled For November 1, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.- benzinga.com Overview Of Value Stocks In The Basic Materials Sector
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 369 companies hit new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 7, 2023
- benzinga.com Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60.
- benzinga.com Earnings Scheduled For August 2, 2023 Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's session, 212 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 137 companies made new 52-week lows.